
Dermatan sulphate sodium
CAS No. 54328-33-5
Dermatan sulphate sodium( —— )
Catalog No. M37544 CAS No. 54328-33-5
Dermatan sulphate sodium, a glycosaminoglycan and thrombin inactivator, exhibits antithrombotic activity by selectively catalyzing the inactivation of thrombin via heparin cofactor II, without interaction with antithrombin III.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 137 | Get Quote |
![]() ![]() |
5MG | 181 | Get Quote |
![]() ![]() |
10MG | 271 | Get Quote |
![]() ![]() |
25MG | 469 | Get Quote |
![]() ![]() |
50MG | 672 | Get Quote |
![]() ![]() |
100MG | 972 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDermatan sulphate sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionDermatan sulphate sodium, a glycosaminoglycan and thrombin inactivator, exhibits antithrombotic activity by selectively catalyzing the inactivation of thrombin via heparin cofactor II, without interaction with antithrombin III.
-
DescriptionDermatan sulphate sodium is a glycosaminoglycan and thrombin inactivator with antithrombotic activity. Dermatan sulphate sodium selectively catalyzes the inactivation of thrombin by heparin cofactor II and does not interact with antithrombin III. Dermatan sulphate sodium is highly bioavailable and also reduces Bleomycin (HY-108345)-induced pulmonary fibrosis damage.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number54328-33-5
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nenci GG. Dermatan sulphate as an antithrombotic drug. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):303-7. ?
molnova catalog



related products
-
Torachrysone gentiob...
Torachrysone gentiobioside is a phenolic glycoside isolated from cassia seeds.
-
Rilematovir
JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.
-
2-Acetyl-4-butyramid...
Gray crystalline powder.